Literature DB >> 7678134

DNA methylation and mutation.

R Holliday1, G W Grigg.   

Abstract

5-Methylcytosine (5mC) in DNA is produced by post-synthetic modification of cytosine residues, and it occurs primarily in CpG doublets in the mammalian genome. 5mC is a mutable site, because it can undergo spontaneous deamination to thymine. There is a repair mechanism which specifically recognises G.T mispairs, and replaces thymine with cytosine. However, this repair is not fully efficient, because the 5mC-->T transition mutation occurs about 10 times as frequently as other transitions. Such mutations are frequently seen in inherited diseases, and mutations in the p53 gene in tumours are also very commonly in 5mCpG doublets. As well as mutations, there can also be heritable changes in DNA methylation, known as epimutations, which may be of particular significance in somatic cells. Whereas the pattern of DNA methylation is very constant for any one cell type, the pattern becomes very variable in tumour cells. The breakdown of the normal controls of DNA methylation in tumorigenesis can lead to increased gene expression or to gene silencing. DNA damage increases not only mutation, but also heritable changes in methylation. At present, little is known about the ability of DNA repair to preserve the normal pattern of methylation in somatic cells.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7678134     DOI: 10.1016/0027-5107(93)90052-h

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  97 in total

1.  A SNP resource for human chromosome 22: extracting dense clusters of SNPs from the genomic sequence.

Authors:  E Dawson; Y Chen; S Hunt; L J Smink; A Hunt; K Rice; S Livingston; S Bumpstead; R Bruskiewich; P Sham; R Ganske; M Adams; K Kawasaki; N Shimizu; S Minoshima; B Roe; D Bentley; I Dunham
Journal:  Genome Res       Date:  2001-01       Impact factor: 9.043

2.  SNP profile within the human major histocompatibility complex reveals an extreme and interrupted level of nucleotide diversity.

Authors:  S Gaudieri; R L Dawkins; K Habara; J K Kulski; T Gojobori
Journal:  Genome Res       Date:  2000-10       Impact factor: 9.043

3.  Enzymatic regional methylation assay: a novel method to quantify regional CpG methylation density.

Authors:  Oliver Galm; Michael R Rountree; Kurtis E Bachman; Kam-Wing Jair; Stephen B Baylin; James G Herman
Journal:  Genome Res       Date:  2002-01       Impact factor: 9.043

4.  Novel TFAP2B mutations that cause Char syndrome provide a genotype-phenotype correlation.

Authors:  F Zhao; C G Weismann; M Satoda; M E Pierpont; E Sweeney; E M Thompson; B D Gelb
Journal:  Am J Hum Genet       Date:  2001-08-14       Impact factor: 11.025

5.  Genetic diversity analysis of abiotic stress response gene TaSnRK2.7-A in common wheat.

Authors:  Hongying Zhang; Xinguo Mao; Jianan Zhang; Xiaoping Chang; Chengshe Wang; Ruilian Jing
Journal:  Genetica       Date:  2011-06-03       Impact factor: 1.082

6.  The CpG island of chicken alpha-globin genes contains no signals sufficient for the maintenance of its nonmethylated state in transgenic mouse genome.

Authors:  E S Ioudinkova; S G Kadulin; I L Gol'dman; S V Razin; L V Verbovaya
Journal:  Dokl Biochem Biophys       Date:  2004 May-Jun       Impact factor: 0.788

Review 7.  Measurements of spontaneous rates of mutations in the recent past and the near future.

Authors:  Fyodor A Kondrashov; Alexey S Kondrashov
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2010-04-27       Impact factor: 6.237

8.  Specific intronic p53 mutation in esophageal squamous cell carcinoma in Southern Thailand.

Authors:  Paramee Thongsuksai; Pleumjit Boonyaphiphat; Puttisak Puttawibul; Wanna Sudhikaran
Journal:  World J Gastroenterol       Date:  2010-11-14       Impact factor: 5.742

Review 9.  Beyond genetics--the emerging role of epigenetic changes in hematopoietic malignancies.

Authors:  Oliver Galm; Manel Esteller
Journal:  Int J Hematol       Date:  2004-08       Impact factor: 2.490

10.  Identification of mutations in the gene for glucose-6-phosphatase, the enzyme deficient in glycogen storage disease type 1a.

Authors:  K J Lei; C J Pan; L L Shelly; J L Liu; J Y Chou
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.